How to Cite
1.
Malpartida Ampudia MK. Premenstrual syndrome. Rev.méd.sinerg. [Internet]. 2017Nov.1 [cited 2024Jul.3];2(11):13-6. Available from: https://revistamedicasinergia.com/index.php/rms/article/view/101
Abstract
Premenstrual syndrome (PMS) is a condition that affects a woman’s behavior, emotions and physical health,these changes appears just before her menses.
It is considered a psychoendocrine disorder. The diagnosis is clinical The key to an effective treatment is accurate diagnosis. Treatment depends on the severity of symptoms.
Keywords
Premenstrual. GABA. psychoendocrine. depression. anxiety. luteal phase.
References
1. ACOG, A. C. (Mayo de 2015). http://www.acog.org. Recuperado el Marzo de 2016, de https://www.acog.org/-/media/For-Patients/faq057.pdf?dmc=1&ts=20170302T1945292228
2. Alan H.DeCherney, M. L. (2013). Diagnostico y tratamiento ginecoobstetricos (11a ed.). Mexico, Mexico DF, Mexico: McGraw-Hill Companies,Inc. Recuperado el 2017
3. AMIR. (2016). Textbook AMIR MEDICINA (Vol. 3). España, España: Marbán.
4. Andréen L, N. S. (Setiembre de 2009). Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Obtenido de https://www.ncbi.nlm.nih.gov/pubmed/19272715
5. Marc A.Freitz, M. S. (2012). Endocrinologia ginecologica clinica y esterilidad (8va ed.). Philadelphia, USA: Wolters Kluwer. Lippincott Williams & Wilkins. Recuperado el 2017
6. Patrick Michael Shaughn O'Brien, K. W. (12 de Enero de 2011). Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. (C. G. Group, Ed.) doi:10.1002/14651858.CD001396.pub3
7. Tracy Nevatte, P. M. (27 de Abril de 2013). ISPMD consensus on the management of premenstrual disorders. National Center for Biotechnology Information (NCBI). Recuperado el 2016, de https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955202.
2. Alan H.DeCherney, M. L. (2013). Diagnostico y tratamiento ginecoobstetricos (11a ed.). Mexico, Mexico DF, Mexico: McGraw-Hill Companies,Inc. Recuperado el 2017
3. AMIR. (2016). Textbook AMIR MEDICINA (Vol. 3). España, España: Marbán.
4. Andréen L, N. S. (Setiembre de 2009). Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Obtenido de https://www.ncbi.nlm.nih.gov/pubmed/19272715
5. Marc A.Freitz, M. S. (2012). Endocrinologia ginecologica clinica y esterilidad (8va ed.). Philadelphia, USA: Wolters Kluwer. Lippincott Williams & Wilkins. Recuperado el 2017
6. Patrick Michael Shaughn O'Brien, K. W. (12 de Enero de 2011). Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. (C. G. Group, Ed.) doi:10.1002/14651858.CD001396.pub3
7. Tracy Nevatte, P. M. (27 de Abril de 2013). ISPMD consensus on the management of premenstrual disorders. National Center for Biotechnology Information (NCBI). Recuperado el 2016, de https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955202.
Downloads
Download data is not yet available.